Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCancer Gene Therapy is a journal focused on gene and cellular therapy for cancer researchers and clinicians.
Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cancer Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Brief Communication
Correspondence
Perspective
Recent Publications
ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells
Yimeng Wang, Zhenghao Li, Ziren Chen, Zhe Yu, Yue Zhang, Chao He, Ruiluan Chen, Yinan Huang, Hang Su, Jingfeng Zhou, Xinmin Fan, Zhiming Li, Yu J. Cao, Yun Chen, Lixin Wang, Zhenghong Lin, Yun Chen, Li Yu, Thomas J. Kipps, Suping Zhang
CircRNA-mediated regulation of ferroptosis in cancer: mechanistic networks and therapeutic implications
Yuliang Zhang, Xingyu Du, Jin Liu, Yujia Guo, Xiaoxia Wang
Restoration of p53 function via hybrid strontium sulfite nanoparticles modified LNP improves the antitumor efficacy in breast cancers
Md Emranul Karim, Mark M. Banaszak Holl, Simon Corrie, Ezharul Hoque Chowdhury
LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma
Lu Zhang, Cheng Kang, Kai Wang
Whole-genome DNA methylation analysis reveals distinct subtype characteristics in epithelial ovarian cancer
Qiaoling Ren, Yingqing Deng, Caizhou Zhong, Dongmei Zhou, Renci Liu, Xiujie Sheng, Deqiang Sun
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision: 5 median days. Submission to acceptance: 138 median days.
Reformat to Cancer Gene Therapy using Livewrite PremiumIs a cover letter required?
A cover letter on institutional letterhead is required at first submission.
Reformat to Cancer Gene Therapy using Livewrite PremiumWhat are the publication costs?
Standard publication is behind a paywall. Gold open access is available with an APC of £2,990 / $4,290 / €3,490, plus VAT or local taxes where applicable.
Reformat to Cancer Gene Therapy using Livewrite Premium